{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:07:21Z","timestamp":1776132441110,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd009447.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:00:00Z","timestamp":1531267200000}}],"reference-count":199,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009447.pub3","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T09:56:31Z","timestamp":1531302991000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Anticoagulation for perioperative thromboprophylaxis in people with cancer"],"prefix":"10.1002","volume":"2019","author":[{"given":"Charbel F","family":"Matar","sequence":"first","affiliation":[{"name":"American University of Beirut Medical Center; Department of Internal Medicine; Riad El Solh Beirut Lebanon 1107 2020"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara A","family":"Kahale","sequence":"additional","affiliation":[{"name":"American University of Beirut; Faculty of Medicine; Beirut Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maram B","family":"Hakoum","sequence":"additional","affiliation":[{"name":"American University of Beirut; Family Medicine; Beirut Lebanon 1107 2020"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim G","family":"Tsolakian","sequence":"additional","affiliation":[{"name":"American University of Beirut; Faculty of Medicine; Beirut Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itziar","family":"Etxeandia-Ikobaltzeta","sequence":"additional","affiliation":[{"name":"McMaster University; Departments of Health Research Methods, Evidence, and Impact and of Medicine; 1280 Main Street West Hamilton ON Canada L8S 4K1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor ED","family":"Yosuico","sequence":"additional","affiliation":[{"name":"Buffalo Medical Group; 85 High Street Buffalo New York USA 14203-1149"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Terrenato","sequence":"additional","affiliation":[{"name":"Regina Elena National Cancer Institute; Biostatistics-Scientific Direction; Via Elio Chianesi 53 Rome Italy 00144"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Sperati","sequence":"additional","affiliation":[{"name":"Regina Elena National Cancer Institute; Biostatistics-Scientific Direction; Via Elio Chianesi 53 Rome Italy 00144"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maddalena","family":"Barba","sequence":"additional","affiliation":[{"name":"IRCCS Regina Elena National Cancer Institute; Division of Medical Oncology 2 - Scientific Direction; Via Elio Chianesi 53 Rome Italy 00144"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Sch\u00fcnemann","sequence":"additional","affiliation":[{"name":"McMaster University; Departments of Health Research Methods, Evidence, and Impact and of Medicine; 1280 Main Street West Hamilton ON Canada L8S 4K1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elie A","family":"Akl","sequence":"additional","affiliation":[{"name":"American University of Beirut Medical Center; Department of Internal Medicine; Riad El Solh Beirut Lebanon 1107 2020"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,7,11]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD009447.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/bjs.5154","article-title":"Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery","volume":"92","author":"Agnelli","year":"2005","journal-title":"British Journal of Surgery"},{"issue":"2","key":"10.1002\/14651858.CD009447.pub3-BIB0002|cit2","first-page":"127","article-title":"Comparison of enoxaparin and standard heparin in gynaecologic oncologic surgery: a randomised prospective double-blind clinical study","volume":"22","author":"Baykal","year":"2001","journal-title":"European Journal of Gynaecological Oncology"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0003|cit3","first-page":"19","article-title":"Thromboprophylactic effect of low molecular weight heparin started in the evening before elective general abdominal surgery: a comparison with low-dose heparin","volume":"16","author":"Bergqvist","year":"1990","journal-title":"Seminars in Thrombosis & Hemostasis"},{"issue":"9","key":"10.1002\/14651858.CD009447.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/bjs.1800750920","article-title":"Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis","volume":"75","author":"Bergqvist","year":"1988","journal-title":"British Journal of Surgery"},{"issue":"8","key":"10.1002\/14651858.CD009447.pub3-BIB0005|cit5","first-page":"1099","article-title":"Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment","volume":"84","author":"Berqvist","year":"1997","journal-title":"British Journal of Surgery"},{"issue":"10","key":"10.1002\/14651858.CD009447.pub3-BIB0006|cit6","first-page":"693","article-title":"Haemostatic molecular markers in patients undergoing radical retropubic prostatectomy for prostate cancer and submitted to prophylaxis with unfractioned or low molecular weight heparin","volume":"67","author":"Boncinelli","year":"2001","journal-title":"Minerva Anestesiologica"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0007|cit7","first-page":"27","article-title":"Prevention of deep venous thromboses in cancer thoracic surgery with a low-molecular-weight heparin: fraxiparine. A comparative randomized trial","volume-title":"Fraxiparine: Second International Symposium Recent Pharmacological and Clinical Data","author":"Dahan","year":"1990"},{"issue":"1","key":"10.1002\/14651858.CD009447.pub3-BIB0008|cit8","first-page":"519 Abstract no","article-title":"Prevention of post-operative deep vein thrombosis (DVT) in malignant patients by fraxiparine (a low molecular weight heparin)","volume":"62","author":"Dahan","year":"1989","journal-title":"Thrombosis and Haemostasis"},{"issue":"11","key":"10.1002\/14651858.CD009447.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/bjs.1800751105","article-title":"Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery","volume":"75","author":"European Fraxiparin Study (EFS) Group","year":"1988","journal-title":"British Journal of Surgery"},{"issue":"6","key":"10.1002\/14651858.CD009447.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2362.1988.tb01268.x","article-title":"Low dose heparin versus low molecular weight heparin (Kabi 2165, Fragmin) in the prophylaxis of thromboembolic complications of abdominal oncological surgery","volume":"18","author":"Fricker","year":"1988","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0011|cit11","first-page":"102","article-title":"Preliminary results of a randomized trial comparing the efficacy of standard heparin with that of fragmine, a low molecular weight heparin, in the prevention of postoperative thrombosis in cancer surgery","volume":"12 Suppl B","author":"Grunebaum","year":"1987","journal-title":"Journal des Maladies Vasculaires"},{"issue":"4","key":"10.1002\/14651858.CD009447.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1055\/s-0038-1649627","article-title":"Orgaran (Org 10172) or heparin for preventing venous thrombosis after elective surgery for malignant disease? A double-blind, randomised, multicentre comparison. ANZ-Organon Investigators' Group","volume":"70","author":"Gallus","year":"1993","journal-title":"Thrombosis and Hemostasis"},{"issue":"6","key":"10.1002\/14651858.CD009447.pub3-BIB0013|cit13","first-page":"647","article-title":"Comparison of the efficacy and safety of subcutaneous Rd heparin vs subcutaneous unfractionated heparin for the prevention of deep-vein thrombosis in patients undergoing abdominal or pelvic-surgery for cancer","volume":"69","author":"Godwin","year":"1993","journal-title":"Thrombosis and Haemostasis"},{"issue":"6","key":"10.1002\/14651858.CD009447.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1378\/chest.122.6.1933","article-title":"Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis","volume":"122","author":"Goldhaber","year":"2002","journal-title":"Chest"},{"issue":"11","key":"10.1002\/14651858.CD009447.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/iju.13189","article-title":"Safety of fondaparinux for prevention of postoperative venous thromboembolism in urological malignancy: a prospective randomized clinical trial","volume":"23","author":"Hata","year":"2016","journal-title":"International Journal of Urology"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s002689900185","article-title":"Efficacy and safety of LMWH and standard UFH for prophylaxis of postoperative venous thromboembolism. European multicenter trial","volume":"21","author":"Kakkar","year":"1997","journal-title":"World Journal of Surgery"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1160\/TH02-10-0189","article-title":"Prevention of fatal pulmonary embolism and mortality in surgical patients: a randomized double-blind comparison of LMWH with unfractionated heparin","volume":"94","author":"Haas","year":"2005","journal-title":"Thrombosis and Haemostasis"},{"issue":"11","key":"10.1002\/14651858.CD009447.pub3-BIB0019|cit18","first-page":"4039","article-title":"Prevention of fatal pulmonary embolism and death in elective cancer surgery patients: a substudy comparison of certoparin with unfractionated heparin","volume":"96","author":"Haas","year":"2000","journal-title":"Blood"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0018|cit19","first-page":"83b","article-title":"Prevention of fatal pulmonary embolism and death in elective cancer surgery patients. A substudy comparison of certoparin with unfractionated heparin","volume":"96 (11 Part 2)","author":"Haas","year":"2000","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD009447.pub3-BIB0020|cit20","first-page":"867","article-title":"Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patients: the MC-4 cancer substudy","volume":"94","author":"Kakkar","year":"2005","journal-title":"Thrombosis and Haemostasis"},{"issue":"6","key":"10.1002\/14651858.CD009447.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1055\/s-0038-1648513","article-title":"Low molecular weight heparin and prevention of postoperative thrombosis in abdominal surgery","volume":"67","author":"Koppenhagen","year":"1992","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0022|cit22","first-page":"593","article-title":"A low molecular weight heparin (KABI 2165) for prophylaxis of postoperative deep venous thrombosis","volume":"152","author":"Onarheim","year":"1986","journal-title":"Acta Chirurgica Scandinavica"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.thromres.2018.04.001","article-title":"Fondaparinux versus nadroparin for thromboprophylaxis following minimally invasive esophagectomy: A randomized controlled trial","volume":"166","author":"Song","year":"2018","journal-title":"Thrombosis research"},{"issue":"3","key":"10.1002\/14651858.CD009447.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-0038-1655988","article-title":"Blood coagulation and thrombosis in patients with ovarian malignancy","volume":"77","author":"Tempelhoff","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"issue":"6","key":"10.1002\/14651858.CD009447.pub3-BIB0025|cit25","first-page":"974","article-title":"A prospective randomized trial of low molecular weight heparin (LMWH) versus unfractionated heparin (UFH) in patients with gynecologic cancer","volume":"73","author":"Heilmann","year":"1996","journal-title":"Thrombosis and Haemostasis"},{"issue":"6","key":"10.1002\/14651858.CD009447.pub3-BIB0026|cit26","first-page":"974","article-title":"A prospective randomized trial of low-molecular-weight heparin (LMWH) versus unfractionated heparin (UFH) in patients with gynecologic cancer","volume":"73","author":"Heilmann","year":"1995","journal-title":"Thrombosis and Haemostasis"},{"issue":"4","key":"10.1002\/14651858.CD009447.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/107602969800400410","article-title":"Comparison of unfractionated versus low molecular weight heparin for deep vein thrombosis prophylaxis during breast and pelvic cancer surgery: efficacy, safety, and follow-up","volume":"4","author":"Heilmann","year":"1998","journal-title":"Clinical and Applied Thrombosis-Hemostasis"},{"issue":"1","key":"10.1002\/14651858.CD009447.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2007-1023030","article-title":"Prevention of postoperative venous thrombosis. A randomized trial comparing low-dose heparin and low molecular weight heparin in gynaecological oncology","volume":"57","author":"Heilmann","year":"1997","journal-title":"Geburtshilfe und Frauenheilkunde"},{"issue":"4","key":"10.1002\/14651858.CD009447.pub3-BIB0029|cit29","first-page":"815","article-title":"Effect of low molecular weight heparin (Certoparin) versus unfractionated heparin on cancer survival following breast and pelvic cancer surgery: a prospective randomized double-blind trial","volume":"16","author":"Tempelhoff","year":"2000","journal-title":"International Journal of Oncology"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0030|cit30","first-page":"54","article-title":"Long-term mortality In 324 gynecological cancer patients after perioperative thrombosis prophylaxis with either low molecular weight heparin (Certoparin (R)) or unfractionated heparin - a double blind randomized prospective trial","volume":"76","author":"Tempelhoff","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009447.pub3-BIB0031|cit31","first-page":"A26","article-title":"Long-term mortality in 324 gynecological cancer patients after perioperative thrombosis prophylaxis with either low molecular weight heparin (Certoparin\u00ae) or unfractionated heparin - a double blind randomized prospective trial","volume":"76","author":"Tempelhoff","year":"1998","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1479-828X.1998.tb02968.x","article-title":"Comparison of low molecular weight heparin (Fragmin) with sodium heparin for prophylaxis against postoperative thrombosis in women undergoing major gynaecological surgery","volume":"38","author":"Ward","year":"1998","journal-title":"Australian & New Zealand Journal of Obstetrics & Gynaecology"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM199807093390204","article-title":"Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery","volume":"339","author":"Agnelli","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"S278","DOI":"10.1016\/j.cjca.2014.07.493","article-title":"Apixaban for the treatment of venous thromboembolism in cancer patients: data from the amplify trial","volume":"30","author":"Agnelli","year":"2014","journal-title":"Canadian Journal of Cardiology"},{"issue":"12","key":"10.1002\/14651858.CD009447.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1111\/jth.13153","article-title":"Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial","volume":"13","author":"Agnelli","year":"2015","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"4","key":"10.1002\/14651858.CD009447.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00001721-200306000-00004","article-title":"Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study","volume":"14","author":"Alikhan","year":"2003","journal-title":"Blood Coagulation & Fibrinolysis"},{"issue":"11","key":"10.1002\/14651858.CD009447.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":"A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients","volume":"341","author":"Samama","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD009447.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/00000658-198111000-00016","article-title":"Deep venous thromboembolism in patients undergoing inguinal lymph node dissection for melanoma","volume":"194","author":"Arbeit","year":"1981","journal-title":"Annals of Surgery"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.ejcts.2009.12.027","article-title":"Randomised high- and low-dose heparin prophylaxis in patients undergoing thoracotomy for benign and malignant disease: effect on thrombo-elastography","volume":"37","author":"Attaran","year":"2010","journal-title":"European Journal of Cardio-thoracic Surgery"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/MBC.0b013e328349f1a8","article-title":"The use of extended perioperative low molecular weight heparin (tinzaparin) to improve disease-free survival following surgical resection of colon cancer: a pilot randomized controlled trial","volume":"22","author":"Auer","year":"2011","journal-title":"Blood Coagulation & Fibrinolysis"},{"issue":"8","key":"10.1002\/14651858.CD009447.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/MBC.0b013e328349f1a8","article-title":"The use of extended perioperative low molecular weight heparin (tinzaparin) to improve disease-free survival following surgical resection of colon cancer: a pilot randomized controlled trial","volume":"22","author":"Auer","year":"2011","journal-title":"Blood Coagulation & Fibrinolysis"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD009447.pub3-BIB0042|cit42","first-page":"11","article-title":"Prospective double-blind comparison between Fragmin and conventional low-dose heparin: thromboprophylactic effect and bleeding complications","volume":"16","author":"Bergqvist","year":"1986","journal-title":"Haemostasis"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/bjs.1800750920","article-title":"Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis","volume":"75","author":"Bergqvist","year":"1988","journal-title":"British Journal of Surgery"},{"issue":"13","key":"10.1002\/14651858.CD009447.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa012385","article-title":"Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer","volume":"346","author":"Bergqvist","year":"2002","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1258\/026835506779115753","article-title":"Prolonged prophylaxis against venous thromboembolism with enoxaparin in patients undergoing cancer surgery: long-term survival analysis","volume":"21","author":"Bergqvist","year":"2006","journal-title":"Phlebology \/ Venous Forum of the Royal Society of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD009447.pub3-BIB0046|cit46","first-page":"502a","article-title":"Prolonged prophylaxis against venous thromboembolism with enoxaparin in patients undergoing surgery for malignancy: 1-year survival study","volume":"100","author":"Bergqvist","year":"2002","journal-title":"Blood Abstract no: P1899"},{"issue":"11","key":"10.1002\/14651858.CD009447.pub3-BIB0047|cit47","first-page":"706A","article-title":"Prolonged thromboprophylaxis in patients undergoing abdominal cancer surgery with Enoxaparin: the Enoxacan II study","volume":"98","author":"Eldor","year":"2001","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD009447.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0090-4295(92)90203-9","article-title":"Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy: a prospective trial","volume":"39","author":"Bigg","year":"1992","journal-title":"Urology"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0049|cit49","first-page":"S21","article-title":"An international multicentre study: Clivarin (R) in the prevention of venous thromboembolism in patients undergoing general surgery","volume":"4","author":"Boneu","year":"1993","journal-title":"Blood Coagulation & Fibrinolysis"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/00016348809004178","article-title":"Comparison of low molecular weight heparin versus unfractionated heparin in gynaecological surgery","volume":"67","author":"Borstad","year":"1988","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/00016349209021097","article-title":"Comparison of low molecular weight heparin versus unfractionated heparin in gynecological surgery","volume":"71","author":"Borstad","year":"1992","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"10","key":"10.1002\/14651858.CD009447.pub3-BIB0052|cit52","first-page":"1004","article-title":"Prevention of thromboembolic disease with heparin-calcium in neurosurgery: evaluation of postoperative hemorrhagic complications","volume":"57","author":"Bricchi","year":"1991","journal-title":"Minerva Anestesiologica"},{"issue":"4","key":"10.1002\/14651858.CD009447.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1445-2197.1983.tb02451.x","article-title":"Prophylaxis of venous thrombosis after major thoracic surgery","volume":"53","author":"Cade","year":"1983","journal-title":"New Zealand Journal of Surgery"},{"issue":"3","key":"10.1002\/14651858.CD009447.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1067\/mva.2000.107572","article-title":"External pneumatic compression and fibrinolysis in abdominal surgery","volume":"32","author":"Cahan","year":"2000","journal-title":"Journal of Vascular Surgery"},{"issue":"3","key":"10.1002\/14651858.CD009447.pub3-BIB0055|cit55","first-page":"147","article-title":"Relative risk of bleeding when starting enoxaparin 2 or 12 hours before surgery for colorectal cancer","volume":"18","author":"Caprini","year":"2003","journal-title":"Phlebology"},{"issue":"5","key":"10.1002\/14651858.CD009447.pub3-BIB0056|cit56","first-page":"290","article-title":"Duration of prophylaxis against thromboembolism after surgery for cancer","volume":"9","author":"Chodri","year":"2002","journal-title":"Clinical Pulmonary Medicine"},{"issue":"7","key":"10.1002\/14651858.CD009447.pub3-BIB0057|cit57","first-page":"S122","article-title":"The effect of warfarin on survival in patients with lung cancer","volume":"7","author":"Ciftci","year":"2012","journal-title":"Journal of Thoracic Oncology"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/0002-9378(83)91205-X","article-title":"Venous thromboembolism prophylaxis in gynecologic oncology: a prospective, controlled trial of low-dose heparin","volume":"145","author":"Clarke-Pearson","year":"1983","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD009447.pub3-BIB0059|cit59","first-page":"689","article-title":"Complications of low-dose heparin prophylaxis in gynecologic oncology surgery","volume":"64","author":"Clarke-Pearson","year":"1984","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD009447.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/0002-9378(93)90360-U","article-title":"A randomized trial of low-dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgery","volume":"168","author":"Clarke-Pearson","year":"1993","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD009447.pub3-BIB0061|cit61","first-page":"684","article-title":"A controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis","volume":"75","author":"Clark-Pearson","year":"1990","journal-title":"Obstetrics & Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD009447.pub3-BIB0062|cit62","first-page":"684","article-title":"A controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis","volume":"75","author":"Clark-Pearson","year":"1990","journal-title":"Obstetrics & Gynecology"},{"issue":"7537","key":"10.1002\/14651858.CD009447.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/bmj.38733.466748.7C","article-title":"Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial","volume":"332","author":"Cohen","year":"2006","journal-title":"BMJ"},{"issue":"7537","key":"10.1002\/14651858.CD009447.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/bmj.38733.466748.7C","article-title":"Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial","volume":"332","author":"Cohen","year":"2006","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD009447.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1358863X07079017","article-title":"Thromboprophylaxis with dalteparin in medical patients: which patients benefit?","volume":"12","author":"Cohen","year":"2007","journal-title":"Vascular Medicine"},{"issue":"7","key":"10.1002\/14651858.CD009447.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.0000138928.83266.24","article-title":"Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients","volume":"110","author":"Leizorovicz","year":"2004","journal-title":"Circulation"},{"issue":"11","key":"10.1002\/14651858.CD009447.pub3-BIB0067|cit67","first-page":"703A","article-title":"A randomized double-blind placebo controlled study of low dose warfarin for the prevention of symptomatic central venous catheter-associated thrombosis in patients with cancer","volume":"100","author":"Anderson","year":"2003","journal-title":"Journal of Thrombosis & Haemostasis: JTH 1, Abstract no: P198"},{"issue":"11","key":"10.1002\/14651858.CD009447.pub3-BIB0068|cit68","first-page":"703A","article-title":"A randomized double-blind placebo-controlled study of low dose warfarin for the prevention of symptomatic central venous catheter-associated thrombosis in patients with cancer","volume":"2769, 100","author":"Couban","year":"2002","journal-title":"Blood"},{"issue":"18","key":"10.1002\/14651858.CD009447.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1200\/JCO.2005.10.192","article-title":"Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer","volume":"23","author":"Couban","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD009447.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00006123-199811000-00039","article-title":"Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors","volume":"43","author":"Dickinson","year":"1998","journal-title":"Neurosurgery"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0071|cit71","first-page":"79","article-title":"Defibrotide in the prevention of deep venous thrombosis in gynecologic surgery. A controlled study versus calcium heparin in 120 patients","volume":"42","author":"Dindelli","year":"1990","journal-title":"Minerva Ginecologica"},{"issue":"1","key":"10.1002\/14651858.CD009447.pub3-BIB0072|cit72","first-page":"83","article-title":"The postoperative prevention of deep venous thrombosis and pulmonary embolism with defibrotide versus heparin-calcium: a randomized clinical multicenter study of 1296 patients undergoing major abdominal surgery","volume":"63","author":"Somma","year":"1992","journal-title":"Annali Italiani di Chirurgia"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hed.2880170102","article-title":"Safety of preoperative enoxaparin in head and neck cancer surgery","volume":"1","author":"Gondret","year":"1995","journal-title":"Head and Neck"},{"issue":"6","key":"10.1002\/14651858.CD009447.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1160\/TH10-09-0614","article-title":"CERTIFY: prophylaxis of venous thromboembolism in patients with severe renal insufficiency","volume":"105","author":"Bauersachs","year":"2011","journal-title":"Thrombosis and Haemostasis"},{"issue":"1","key":"10.1002\/14651858.CD009447.pub3-BIB0075|cit75","first-page":"A10","article-title":"CERTIFY: certoparin versus UFH to prevent venous thromboembolic events in the patients with cancer","volume":"31","author":"Haas","year":"2011","journal-title":"H\u00e4mostaseologie"},{"issue":"1","key":"10.1002\/14651858.CD009447.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-11-316","article-title":"Heparin based prophylaxis to prevent venous thromboembolic events and death in patients with cancer-a subgroup analysis of CERTIFY","volume":"11","author":"Haas","year":"2011","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1002\/14651858.CD009447.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000217198","article-title":"Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients","volume":"26","author":"Harenberg","year":"1996","journal-title":"Pathophysiology of Haemostasis and Thrombosis"},{"issue":"1","key":"10.1002\/14651858.CD009447.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0049-3848(92)90125-T","article-title":"Heparin Study in Internal Medicine (HESIM): design and preliminary results","volume":"68","author":"Harenberg","year":"1992","journal-title":"Thrombosis Research"},{"issue":"2","key":"10.1002\/14651858.CD009447.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/BF02237127","article-title":"Randomized, controlled trial of low molecular weight heparin vs. no deep vein thrombosis prophylaxis for major colon and rectal surgery in Asian patients","volume":"42","author":"Ho","year":"1999","journal-title":"Diseases of the Colon & Rectum"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0080|cit80","first-page":"1952","article-title":"Prolonged thromboprophylaxis with low-molecular weight heparin following major general surgery: an individual patient data meta-analysis","volume":"100","author":"Jorgensen","year":"2002","journal-title":"Blood"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/bjs.1800721006","article-title":"Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: a co-operative study","volume":"72","author":"Kakkar","year":"1985","journal-title":"British Journal of Surgery"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0002-9610(89)90589-8","article-title":"Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis","volume":"157","author":"Kakkar","year":"1989","journal-title":"American Journal of Surgery"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD009447.pub3-BIB0083|cit83","first-page":"1","article-title":"Late breaking clinical trial: a randomised double blind trial to evaluate the efficacy and safety of prolonging the thromboprophylaxis with bemiparin in patients undergoing cancer abdominal or pelvic surgery (the CANBESURE study)","volume":"7","author":"Kakkar","year":"2009","journal-title":"International Society on Thrombosis and Haemostasis"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD009447.pub3-BIB0084|cit84","first-page":"1202, LB-MO-002","article-title":"Late breaking clinical trial: a randomised double blind trial to evaluate the efficacy and safety of prolonging the thromboprophylaxis with bemiparin in patients undergoing cancer abdominal or pelvic surgery (the CANBESURE study)","volume":"7","author":"Kakkar","year":"2009","journal-title":"International Society on Thrombosis and Haemostasis"},{"issue":"6","key":"10.1002\/14651858.CD009447.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1538-7836.2010.03892.x","article-title":"Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study","volume":"8","author":"Kakkar","year":"2010","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1538-7836.2010.03892.x","article-title":"Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study","volume":"8","author":"Kakkar","year":"2010","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood.V116.21.188.188","article-title":"The ultra-low-molecular-weight heparin semuloparin for prevention of venous thromboembolism in patients undergoing major abdominal surgery","volume":"116","author":"Kakkar","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1002\/14651858.CD009447.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/SLA.0000000000000430","article-title":"Preoperative enoxaparin versus postoperative semuloparin thromboprophylaxis in major abdominal surgery: a randomized controlled trial","volume":"259","author":"Kakkar","year":"2014","journal-title":"Annals of Surgery"},{"issue":"21","key":"10.1002\/14651858.CD009447.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood.V116.21.188.188","article-title":"The ultra-low-molecular-weight heparin semuloparin for prevention of venous thromboembolism in patients undergoing major abdominal surgery","volume":"116","author":"Kakkar","year":"2010","journal-title":"Blood"},{"issue":"23","key":"10.1002\/14651858.CD009447.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1182\/blood.V126.23.427.427","article-title":"Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: a randomized trial","volume":"126","author":"Khorana","year":"2015","journal-title":"Blood"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0091|cit91","doi-asserted-by":"crossref","unstructured":"Khorana AA Francis CW Kuderer N Carrier M Ortel TL Wun T Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: a randomized trial Thrombosis Research 2017 dx.doi.org\/10.1016\/j.thromres.2017.01.009","DOI":"10.1016\/j.thromres.2017.01.009"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1182\/blood-2011-03-344333","article-title":"Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide","volume":"119","author":"Larocca","year":"2012","journal-title":"Blood"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/110241598750005534","article-title":"Incidence and prevention of deep venous thrombosis occurring late after general surgery: randomised controlled study of prolonged thromboprophylaxis","volume":"164","author":"Lausen","year":"1998","journal-title":"European Journal of Surgery"},{"issue":"1","key":"10.1002\/14651858.CD009447.pub3-BIB0094|cit94","first-page":"284","article-title":"Catch-a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients","volume":"13","author":"Bauersachs","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0095|cit95","first-page":"76","article-title":"Long-term tinzaparin versus warfarin for treatment of venous thromboembolism (VTE) in cancer patients-analysis of renal impairment (RI) in the catch study","volume":"13","author":"Bauersachs","year":"2015","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0096|cit96","first-page":"182","article-title":"Characteristics and risk factors of major and clinically relevant non-major bleeding in cancer patients receiving anticoagulant treatment for acute venous thromboembolism - the CATCH study","volume":"13","author":"Kamphuisen","year":"2015","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"15 (Suppl 1)","key":"10.1002\/14651858.CD009447.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"9621","DOI":"10.1200\/jco.2015.33.15_suppl.9621","article-title":"Clinical predictors of recurrent venous thromboembolism (VTE) in cancer patients from a randomized trial of long-term tinzaparin versus warfarin for treatment: the CATCH study","volume":"33","author":"Khorana","year":"2015","journal-title":"Journal of Clinical Oncology Conference"},{"issue":"1","key":"10.1002\/14651858.CD009447.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/1471-2407-13-284","article-title":"CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients","volume":"13","author":"Lee","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0100|cit99","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.9243","article-title":"Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: a randomized clinical trial","volume":"314","author":"Lee","year":"2015","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0099|cit100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/blood.V124.21.LBA-2.LBA-2","article-title":"A randomized trial of long-term tinzaparin, a low molecular weight heparin (LMWH), versus warfarin for treatment of acute venous thromboembolism (VTE) in cancer patients - the CATCH study","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/bjs.1800780410","article-title":"Prevention of perioperative deep vein thrombosis in general surgery double blind study comparing two doses of logiparin and standard heparin","volume":"78","author":"Liezorovicz","year":"1991","journal-title":"British Journal of Surgery"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/BF00190751","article-title":"Prospective randomized clinical study in general surgery comparing a new low molecular weight heparin with unfractionated heparin in the prevention of thrombosis","volume":"72","author":"Limmer","year":"1994","journal-title":"Clinical Investigator"},{"issue":"1","key":"10.1002\/14651858.CD009447.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-9-355","article-title":"FRAGMATIC: a randomised phase III clinical trial investigating the effect of Fragmin\u00ae added to standard therapy in patients with lung cancer","volume":"9","author":"Griffiths","year":"2009","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1002\/14651858.CD009447.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1200\/JCO.2015.64.0268","article-title":"Randomized phase III trial of standard therapy plus low molecular weight heparin in patients with lung cancer: FRAGMATIC trial","volume":"34","author":"Macbeth","year":"2016","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0105|cit105","first-page":"S243","article-title":"Preliminary results from the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of Fragmin (R) added to standard therapy in patients with lung cancer","volume":"8","author":"Macbeth","year":"2013","journal-title":"Journal of Thoracic Oncology"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0106|cit106","first-page":"143","article-title":"Prediction of venous thromboembolism in lung cancer patients receiving chemotherapy","volume":"13","author":"Noble","year":"2015","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0090-3019(03)00111-3","article-title":"Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy","volume":"59","author":"Macdonald","year":"2003","journal-title":"Surgical Neurology"},{"issue":"2","key":"10.1002\/14651858.CD009447.pub3-BIB0108|cit108","first-page":"166","article-title":"Prevention of postoperative deep vein thrombosis in cancer patients. A randomized trial with low molecular weight heparin (CY 216)","volume":"78","author":"Marassi","year":"1993","journal-title":"International Surgery"},{"issue":"6","key":"10.1002\/14651858.CD009447.pub3-BIB0109|cit109","first-page":"989","article-title":"Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: a randomized trial","volume":"98","author":"Maxwell","year":"2001","journal-title":"American College of Obstetricians and Gynecologists"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009447.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"S39, P221","DOI":"10.1093\/cvr\/cvu082.154","article-title":"Venous thromboembolism: secondary prevention with dabigatran vs. acenocumarol in patients with paraneoplastic deep vein thrombosis. Results from a small prospective study in Romania","volume":"103","author":"Mazilu","year":"2014","journal-title":"Cardiovascular Research"},{"issue":"3","key":"10.1002\/14651858.CD009447.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1067\/mva.2000.107572","article-title":"External pneumatic compression and fibrinolysis in abdominal surgery","volume":"32","author":"Cahan","year":"2000","journal-title":"Journal of Vascular Surgery"},{"issue":"5","key":"10.1002\/14651858.CD009447.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1067\/mva.2002.128940","article-title":"External pneumatic compression does not increase urokinase plasminogen activator after abdominal surgery","volume":"36","author":"Murakami","year":"2002","journal-title":"Journal of Vascular Surgery"},{"issue":"9","key":"10.1002\/14651858.CD009447.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/jog.12740","article-title":"Randomized controlled trial of enoxaparin versus intermittent pneumatic compression for venous thromboembolism prevention in Japanese surgical patients with gynecologic malignancy","volume":"41","author":"Nagata","year":"2015","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"issue":"6","key":"10.1002\/14651858.CD009447.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0002-9610(99)80222-0","article-title":"A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery","volume":"169","author":"Nurmohamed","year":"1995","journal-title":"American Journal of Surgery"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1055\/s-0038-1650250","article-title":"Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery","volume":"75","author":"Nurmohamed","year":"1996","journal-title":"Thrombosis Haemostasis"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0116|cit116","first-page":"391","article-title":"Phase III study of enoxaparin versus aspirin versus low-dose warfarin as thromboprophylaxis for patients with newly diagnosed multiple myeloma treated upfront with thalidomide-containing regimens","volume":"95","author":"Cavo","year":"2010","journal-title":"Haematologica"},{"issue":"11","key":"10.1002\/14651858.CD009447.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1182\/blood.V112.11.3017.3017","article-title":"A phase III study of enoxaparin versus low-dose warfarin versus aspirin as thromboprophylaxis for patients with newly diagnosed multiple myeloma treated up-front with thalidomide-containing regimens","volume":"112","author":"Cavo","year":"2008","journal-title":"Blood"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0118|cit118","first-page":"s4","article-title":"A phase III study of enoxaparin versus low-dose warfarin versus aspirin as thromboprophylaxis for patients with newly diagnosed multiple myeloma treated up-front with thalidomide-containing regimens","volume":"94","author":"Cavo","year":"2009","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0119|cit119","first-page":"986","article-title":"Enoxaparin, aspirin, or warfarin for the thromboprophylaxis in newly diagnosed myeloma patients receiving thalidomide: a randomized controlled trial","volume":"95","author":"Magarotto","year":"2010","journal-title":"XI Congress of the Italian Society of Experimental Hematology"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0120|cit120","first-page":"362","article-title":"Enoxaparin versus aspirin versus low-fixed-dose of warfarin in newly diagnosed myeloma patients treated with thalidomide-containing regimens: a randomized, controlled trial","volume":"93","author":"Palumbo","year":"2008","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1200\/JCO.2010.31.6844","article-title":"Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial","volume":"29","author":"Palumbo","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0122|cit122","unstructured":"Pelzer U Deutschinoff G Opitz B Stauch M Reitzig P Hahnfeld S A prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy - first results of the CONKO 004 trial Onkologie - DGHO meeting October 2009 Abstract"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD009447.pub3-BIB0123|cit123","first-page":"54","article-title":"A prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy (PROSPECT - CONKO 004)","volume":"28","author":"Pelzer","year":"2005","journal-title":"Onkologie"},{"issue":"18","key":"10.1002\/14651858.CD009447.pub3-BIB0124|cit124","first-page":"4110","article-title":"A prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy (PROSPECT-CONKO 004)","volume":"24","author":"Pelzer","year":"2006","journal-title":"ASCO Annual Meeting Proceedings"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/1471-2407-14-204","article-title":"Intensified chemotherapy and simultaneous treatment with heparin in outpatients with pancreatic cancer - the CONKO 004 pilot trial","volume":"14","author":"Pelzer","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0126|cit126","unstructured":"Pelzer U Oettle H Stauch M Opitz B Stieler J Scholten T Prospective, randomized open trial of enoxaparin in patients with advanced pancreatic cancer undergoing first-line chemotherapy XXIst Congress of the International Society on Thrombosis and Haemostasis; 2007 Jul 6-12; Geneva 2007 P T-488"},{"issue":"18","key":"10.1002\/14651858.CD009447.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1200\/JCO.2014.55.1481","article-title":"Efficacy of prophylactic low-molecular weight heparin for ambulatory patients with advanced pancreatic cancer: outcomes from the CONKO-004 Trial","volume":"33","author":"Pelzer","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"18S","key":"10.1002\/14651858.CD009447.pub3-BIB0128|cit128","first-page":"LBA4506","article-title":"A prospective, randomized trial of chemotherapy with or without the low molecular weight heparin (LMWH) enoxaparin in patients (pts) with advanced pancreatic cancer (APC): results of the CONKO 004 trial","volume":"27","author":"Riess","year":"2009","journal-title":"ASCO Annual Meeting Proceedings"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/1471-2407-8-361","article-title":"Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy","volume":"8","author":"Riess","year":"2008","journal-title":"BMC Cancer"},{"issue":"15 Suppl","key":"10.1002\/14651858.CD009447.pub3-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1200\/jco.2010.28.15_suppl.4033","article-title":"A prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy: final results of the CONKO-004 trial","volume":"28","author":"Riess","year":"2010","journal-title":"Journal of Clinical Oncology Conference"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD009447.pub3-BIB0131|cit131","first-page":"1203","article-title":"Late breaking clinical trial: a prospective, randomized trial of chemotherapy with and without the low molecular weight heparin (LMWH) enoxaparin in advanced pancreatic cancer patients","volume":"7","author":"Riess","year":"2009","journal-title":"International Society on Thrombosis and Haemostasis"},{"issue":"1","key":"10.1002\/14651858.CD009447.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/S2352-3026(14)70018-3","article-title":"Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials","volume":"1","author":"Prins","year":"2014","journal-title":"Lancet Haematology"},{"issue":"8","key":"10.1002\/14651858.CD009447.pub3-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1016\/S2352-3026(16)30057-6","article-title":"Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial","volume":"3","author":"Raskob","year":"2016","journal-title":"Lancet Haematology"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"LBA","DOI":"10.1182\/blood.V130.Suppl_1.LBA-6.LBA-6","article-title":"A randomized, open-label, blinded outcome assessment trial evaluating the efficacy and safety of LMWH\/edoxaban versus dalteparin for venous thromboembolism associated with cancer: Hokusai VTE-Cancer study (LBA-6)","volume":"130","author":"Raskob","year":"2017","journal-title":"Blood"},{"issue":"7","key":"10.1002\/14651858.CD009447.pub3-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJMoa1711948","article-title":"Edoxaban for the treatment of cancer-associated venous thromboembolism","volume":"378","author":"Raskob","year":"2018","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0136|cit136","first-page":"186","article-title":"Prolonged thromboprophylaxis with low molecular weight heparin (dalteparin) following major abdominal surgery for malignancy","volume":"102","author":"Rasmussen","year":"2003","journal-title":"Blood"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0137|cit137","first-page":"407a","article-title":"Prolonged thromboprophylaxis with dalteparin after major abdominal surgery for malignant diseases","volume":"4","author":"Rasmussen","year":"2001","journal-title":"ASCO Proceedings"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1111\/j.1538-7836.2006.02153.x","article-title":"Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study","volume":"4","author":"Rasmussen","year":"2006","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"3","key":"10.1002\/14651858.CD009447.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.thromres.2009.09.009","article-title":"Efficacy and safety of enoxaparin in Japanese patients undergoing curative abdominal or pelvic cancer surgery: results from a multicenter, randomized, open-label study","volume":"125","author":"Sakon","year":"2010","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/bjs.1800750213","article-title":"Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis","volume":"75","author":"Samama","year":"1988","journal-title":"British Journal of Surgery"},{"issue":"18","key":"10.1002\/14651858.CD009447.pub3-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa030104","article-title":"Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran","volume":"349","author":"Schulman","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD009447.pub3-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1113697","article-title":"Extended use of dabigatran, warfarin, or placebo in venous thromboembolism","volume":"368","author":"Schulman","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD009447.pub3-BIB0143|cit143","first-page":"150","article-title":"Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer","volume":"114","author":"Schulman","year":"2015","journal-title":"Thrombosis and Haemostasis"},{"issue":"2","key":"10.1002\/14651858.CD009447.pub3-BIB0144|cit144","first-page":"71","article-title":"Postoperative deep vein thrombosis in patients with colorectal cancer","volume":"27","author":"Shukla","year":"2008","journal-title":"Indian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/j.1538-7836.2006.02083.x","article-title":"A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40mg) in the prevention of venous thromboembolism after colorectal surgery for cancer","volume":"4","author":"Simonneau","year":"2006","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"13","key":"10.1002\/14651858.CD009447.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1245\/s10434-014-3893-1","article-title":"Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial","volume":"21","author":"Song","year":"2014","journal-title":"Annals of Surgical Oncology"},{"issue":"39","key":"10.1002\/14651858.CD009447.pub3-BIB0147|cit147","first-page":"2768","article-title":"Evaluation of efficacy and safety of rivaroxaban in the prevention of postoperative venous thromboembolism in adult patients with primary bone tumor undergoing knee operation","volume":"92","author":"Tang","year":"2012","journal-title":"Zhonghua Yi Xue za Zhi"},{"issue":"21","key":"10.1002\/14651858.CD009447.pub3-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1182\/blood.V122.21.580.580","article-title":"Randomized controlled trial of dalteparin for primary thromboprophylaxis for venous thromboembolism (VTE) in patients with advanced pancreatic cancer (APC): risk factors predictive of VTE","volume":"122","author":"Vadhan-Raj","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD009447.pub3-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.3324\/haematol.2014.109843","article-title":"Incidence and risk factors for venous thromboembolism after laparoscopic surgery for colorectal cancer","volume":"100","author":"Becattini","year":"2014","journal-title":"Haematologia"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.3324\/haematol.2014.109843","article-title":"Letter to the editor. Incidence and risk factors for venous thromboembolism after laparoscopic surgery for colorectal cancer","volume":"100","author":"Becattini","year":"2015","journal-title":"Haematologia"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0151|cit151","first-page":"11","article-title":"One week vs. four week heparin prophylaxis after laparoscopic surgery for colorectal cancer. The pro-laps pilot feasibility study","volume":"11","author":"Becattini","year":"2013","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0152|cit152","first-page":"214","article-title":"A randomized study on 1 vs. 4 weeks prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer","volume":"11","author":"Vedovati","year":"2013","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"4","key":"10.1002\/14651858.CD009447.pub3-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/SLA.0000000000000340","article-title":"A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer","volume":"259","author":"Vedovati","year":"2014","journal-title":"Annals of Surgery"},{"issue":"1","key":"10.1002\/14651858.CD009447.pub3-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.3324\/haematol.2014.109843","article-title":"Incidence and risk factors for venous thromboembolism after laparoscopic surgery for colorectal cancer","volume":"100","author":"Becattini","year":"2015","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0155|cit155","first-page":"ATT05, 1-105","article-title":"One week vs. four week heparin prophylaxis after laparoscopic surgery for colorectal cancer. The pro-laps pilot feasibility study","volume":"11","author":"Becattini","year":"2013","journal-title":"International Society on Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0156|cit156","first-page":"214","article-title":"A randomized study on 1 vs. 4 weeks prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer","volume":"11","author":"Vedovati","year":"2013","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"4","key":"10.1002\/14651858.CD009447.pub3-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/SLA.0000000000000340","article-title":"A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer","volume":"259","author":"Vedovati","year":"2014","journal-title":"Annals of Surgery"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"734S","DOI":"10.1200\/jco.2004.22.90140.8021","article-title":"A double-blind placebo-controlled randomized study on the efficacy and safety of enoxaparin for the prevention of upper limb deep vein thrombosis in cancer patients with central vein catheter","volume":"22","author":"Agnelli","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"18","key":"10.1002\/14651858.CD009447.pub3-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1200\/JCO.2005.06.084","article-title":"Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients","volume":"23","author":"Verso","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD009447.pub3-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11739-008-0125-3","article-title":"Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients","volume":"3","author":"Verso","year":"2008","journal-title":"Internal and Emergency Medicine"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0161|cit161","first-page":"8021","article-title":"A double-blind placebo-controlled randomized study on the efficacy and safety of enoxaparin for the prevention of upper limb deep vein thrombosis in cancer patients with central vein catheter","author":"Verso","year":"2008","journal-title":"Journal of Thrombosis and Haemostasis : JTH"},{"issue":"15 Suppl","key":"10.1002\/14651858.CD009447.pub3-BIB0162|cit162","first-page":"TPS9661","article-title":"SELECT-D: anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism","volume":"32","author":"Young","year":"2014","journal-title":"ASCO Annual Meeting Proceedings"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0163|cit163","first-page":"625","article-title":"Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism: results of the Select-D\u2122 pilot trial","volume":"130","author":"Young","year":"2017","journal-title":"Blood"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1016\/S0049-3848(16)30128-1","article-title":"OC-11-Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism","volume":"140","author":"Young","year":"2016","journal-title":"Thrombosis Research"},{"issue":"15 Suppl","key":"10.1002\/14651858.CD009447.pub3-BIB0165|cit165","first-page":"TPS9642","article-title":"Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism","volume":"33","author":"Young","year":"2015","journal-title":"ASCO Annual Meeting Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD009447.pub3-BIB0166|cit166","first-page":"39","article-title":"Prophylactic use of low molecular weight heparin in combination with graduated compression stockings in post-operative patients with gynecologic cancer","volume":"36","author":"Zheng","year":"2014","journal-title":"Zhonghua Zhong Liu za Zhi [Chinese Journal of Oncology]"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0167|cit167","first-page":"6","article-title":"A randomized-controlled phase II trial of primary thromboprophylaxis with enoxaparin in cancer patients with elevated tissue factor bearing microparticles (the MICROTEC study)","volume":"11","author":"Zwicker","year":"2013","journal-title":"Journal of Thrombosis and Haemostasis : JTH"},{"issue":"4","key":"10.1002\/14651858.CD009447.pub3-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/bjh.12163","article-title":"Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study)","volume":"160","author":"Zwicker","year":"2013","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0169|cit169","unstructured":"A Randomized, Controlled, Open Label Study of the Efficacy and Safety of the Low Molecular Weight Heparin (LMWH), Lovenox TM (Enoxaparin) versus Heparin TM (Unfractionated Heparin) for Prevention of Venous Thromboembolism (VTE) in Gynecologic Oncology Patients Ongoing study October 2009"},{"issue":"2","key":"10.1002\/14651858.CD009447.pub3-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"e57132","DOI":"10.1371\/journal.pone.0057132","article-title":"Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers","volume":"8","author":"Akl","year":"2013","journal-title":"PloS One"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jclinepi.2016.02.022","article-title":"Three challenges described for identifying participants with missing data in trials reports, and potential solutions suggested to systematic reviewers","volume":"76","author":"Akl","year":"2016","journal-title":"Journal of Clinical Epidemiology"},{"issue":"11","key":"10.1002\/14651858.CD009447.pub3-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"e49163","DOI":"10.1371\/journal.pone.0049163","article-title":"Inconsistent definitions for intention-to-treat in relation to missing outcome data: systematic review of the methods literature","volume":"7","author":"Alshurafa","year":"2012","journal-title":"PloS One"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(60)92299-6","article-title":"Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial","volume":"1","author":"Barritt","year":"1960","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1463-1318.2004.00734.x","article-title":"Systematic review of thromboprophylaxis in colorectal surgery","volume":"7","author":"Borly","year":"2005","journal-title":"Colorectal Disease"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"562","DOI":"10.2146\/ajhp120711","article-title":"Comparison of injectable anticoagulants for thromboprophylaxis after cancer-related surgery","volume":"7","author":"Changolkar","year":"2014","journal-title":"American Journal of Health-system Pharmacy"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0176|cit176","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926.ch15","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis","volume-title":"Systematic Reviews in Health Care: Meta-Analysis in Context","author":"Deeks","year":"2001"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"9","key":"10.1002\/14651858.CD009447.pub3-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jclinepi.2013.03.014","article-title":"Addressing continuous data for participants excluded from trial analysis: a guide for systematic reviewers","volume":"66","author":"Ebrahim","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD009447.pub3-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1445-1433.2004.03258.x","article-title":"Evidence-based risk factors for postoperative deep vein thrombosis","volume":"74","author":"Edmonds","year":"2004","journal-title":"ANZ Journal of Surgery"},{"issue":"3","key":"10.1002\/14651858.CD009447.pub3-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ygyno.2007.03.004","article-title":"Venous thromboembolism prevention in gynecologic cancer surgery: a systematic review","volume":"105","author":"Einstein","year":"2007","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0181|cit181","first-page":"783","article-title":"Risk factors for major thromboembolism and bleeding tendency after elective general surgical operations","volume":"162","author":"Flordal","year":"1996","journal-title":"European Journal of Surgery"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1055\/s-0038-1657514","article-title":"Prevention of post-operative deep leg vein thrombosis in patients with cancer","volume":"78","author":"Gallus","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD009447.pub3-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"e227S","DOI":"10.1378\/chest.11-2297","article-title":"Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Gould","year":"2012","journal-title":"Chest"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0184|cit184","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A GRADE Handbook, Updated October 2013 gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jclinepi.2017.05.005","article-title":"GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence","volume":"87","author":"Guyatt","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0187|cit187","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration Available from handbook.cochrane.org"},{"issue":"1","key":"10.1002\/14651858.CD009447.pub3-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-0038-1646191","article-title":"Low molecular weight heparin","volume":"70","author":"Hirsh","year":"1993","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0002-9610(70)80023-X","article-title":"Deep vein thrombosis of the leg. Is there a \"high risk\" group?","volume":"120","author":"Kakkar","year":"1970","journal-title":"American Journal of Surgery"},{"issue":"2","key":"10.1002\/14651858.CD009447.pub3-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1245\/s10434-006-9183-9","article-title":"A systematic review of deep venous thrombosis prophylaxis in cancer patients: implications for improving quality","volume":"14","author":"Leonardi","year":"2007","journal-title":"Annals of Surgical Oncology"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00005792-199909000-00001","article-title":"Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy","volume":"78","author":"Levitan","year":"1999","journal-title":"Medicine"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","article-title":"Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis","volume":"106","author":"Martel","year":"2005","journal-title":"Blood"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.0007-1323.2001.01800.x","article-title":"Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery","volume":"88","author":"Mismetti","year":"2001","journal-title":"British Journal of Surgery"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1378\/chest.06-2518","article-title":"No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low-molecular-weight heparin or unfractionated heparin","volume":"132","author":"Morris","year":"2007","journal-title":"Chest"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00001721-199203040-00012","article-title":"Venous thromboembolism and cancer","volume":"3","author":"Rahr","year":"1992","journal-title":"Blood Coagulation & Fibrinolysis"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0196|cit196","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD009447.pub3-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","article-title":"Prognosis of cancers associated with venous thromboembolism","volume":"343","author":"Sorensen","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD009447.pub3-BIB0198|cit198","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009447.pub2","article-title":"Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer","author":"Akl","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD009447.pub3-BIB0199|cit199","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009447","article-title":"Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer","author":"Akl","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD009447.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T17:11:17Z","timestamp":1693761077000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009447.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,7,11]]},"references-count":199,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009447.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,11]]}}}